Navigation Links
UCB Crohn's Scholarship Program to Award $300,000 to Students with Crohn's Disease

Scholarship rewards remarkable individuals who break the boundaries of

living with Crohn's

ATLANTA, Jan. 10 /PRNewswire/ -- UCB announced today the launch of the 2008 UCB Crohn's Scholarship Program, which will award 30, one-time scholarships of up to $10,000 each to students diagnosed with Crohn's disease who demonstrate academic ambition and drive to reach beyond the boundaries of their condition. Applications for the scholarship are now available at Winners will be selected by a team of gastroenterologists from leading institutions across the country.

"I am humbled each year as the scholarship applications are submitted. The applicants are truly remarkable," said David Robinson, Vice President, Immunology Business Unit, UCB. "Their determination and perseverance, despite the many challenges they face due to Crohn's, is an inspiration and a credit to their own drive and fortitude. They are all gifted individuals, and I have no doubt they will reach their academic and personal goals."

Previous scholarship recipients include individuals who have shown a passion to pursue their academic dreams despite the challenges posed by Crohn's disease. One previous winner from the 2007 program, Riva Litman, is a senior at the University of California, Berkeley. Ms. Litman impressed the selection committee with her ambitious dedication to improving the lives of all people with Crohn's. As a high school student in California, Riva was dealing with overwhelming ailments, including hospitalizations related to Crohn's. Yet, Riva had the courage to board a plane to Washington, D.C., to lobby for funding for research in Inflammatory Bowel Disease (IBD). Her experience ignited a passion for public policy that has continued to grow. Riva can also be proud of her recent prestigious internship in the Office of Presidential Speechwriting at the White House for the President of the United States.

"Despite having lived with Crohn's since I was fifteen-years-old, I have never let it impede my ability to achieve the goals I've set for myself," said Riva. "The scholarship stands for everything I believe in: that one can truly succeed in the wake of challenges. I am passionate about law, public policy, and politics and hope that my fight to seek funding for and promote awareness of Crohn's can someday make an impact on the lives of others who, like me, are affected by it."

The 2008 UCB Crohn's Scholarship Program builds on $420,000 in UCB scholarships granted in 2006 and 2007 for people with Crohn's seeking higher education. UCB launched the scholarship pilot program in 2006 and awarded 12 recipients scholarships of up to $10,000 each. In 2007, UCB continued the program awarding academic excellence and perseverance by providing 31 students from across the country with one-time scholarships of up to $10,000 each. Select winner biographies can be found online at

Applications Now Available for the 2008 Program

Scholarship applications are available at, an interactive Web site designed to connect people living with Crohn's disease and their supporters and empower them to live fully and be proactive in their care. The application deadline is April 18, 2008 and winners will be notified in July 2008.

The program is designed for applicants of any age. Applicants must be legal and permanent residents of the United States; diagnosed with Crohn's disease by a physician; seeking an associate's, undergraduate, or graduate degree or enrolled in a trade school educational program; enrolled in or awaiting acceptance from a United States-based institution of higher education for fall semester 2008 and a student who demonstrates academic ambition and embraces a way of life that overcomes the boundaries of living with Crohn's disease.

Employees of UCB and their immediate family members are not eligible for this scholarship. Selection of recipients will be at the sole discretion of the physician panel members. After a winner's educational enrollment has been verified for the fall 2008 semester, the scholarship check will be made payable to and directly mailed to the educational institution. Scholarship amounts will be up to $10,000 each to cover the recipient's tuition and/or educational materials expenses. However, if a student does not have a minimum of $10,000 in educational expenses owed for his/her schooling, the scholarship amount will only cover the remaining amount. Scholarship money cannot be used towards expenses other than those due to the school for education expenses. If UCB learns that an applicant does not have any remaining costs owed to the academic institution, he/she will no longer be eligible for the scholarship. Winners of the 2006 and 2007 scholarship programs are not eligible for the 2008 scholarship program.

About Crohn's Disease

Crohn's disease is a chronic and debilitating inflammatory disease of the gastrointestinal tract, affecting more than 500,000 people in the United States. Crohn's is a lifelong chronic condition, but most people are diagnosed in their late teens and early twenties. Crohn's sufferers go through unpredictable periods when the disease flares up and causes symptoms. These episodes are often followed by times of remission - periods in which symptoms disappear or decrease and good health returns.

2007 Program Scholarship Recipients

UCB has announced the recipients of the 2007 scholarships, which were awarded to 31 students across the country. Recipients were considered based on their applications, personal essays, and letters of recommendation and include:
-- Alex Akers, University of California, Los Angeles

-- Stephanie Bachas-Daunert, Princeton University

-- Samuel Barnes, University of Utah

-- Brittni Bryant, Auburn University

-- Nikelia Chisolm, Teachers College, Columbia University

-- Lisa Clavel, Peninsula College

-- Jessica Cope, University of California, Santa Barbara

-- Jordan Fifer, Virginia Western Community College

-- Aimee Frisch, University of Wisconsin, Oshkosh

-- Tayler Harvey, University of North Carolina Wilmington

-- Tiffany Havlicek, The Chicago School of Professional Psychology

-- Jennifer Higdon, East Carolina University

-- Kelly Horton, University of Arkansas, Little Rock

-- Julie Michelle Katrichis, University of Wisconsin, Milwaukee

-- Rachel King, Illinois State University

-- Melissa Kwaterski, Marquette University

-- Sarah Listug, Creighton University, School of Pharmacy and Health


-- Riva Litman, University of California, Berkeley

-- Laura Maples, Virginia Tech

-- Michael Margherita, Lehigh University

-- Marissa Moffitt, Chapman University

-- Grace O'Shea, Colgate University

-- Kendall Plageman, College of William and Mary - School of Education

-- Jill Plevinsky, The George Washington University

-- Charlotte Roche, Central Michigan University

-- Lydia Rosenbaum, Mount Mary College - Columbia College of Nursing

-- Rajesh Shah, The University of Texas Southwestern Medical School

-- Jordyn Shapiro, New York Institute of Technology

-- Nathan Tanoue, Taylor University

-- Jordan Valinsky, Ohio University

-- Michael Schacht, Indiana University School of Medicine

About UCB

UCB is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialization of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology. Employing approximately 12,000 people in more than 40 countries, UCB achieved revenue of $4.6 billion (3.5 billion euro) in 2006 on a pro forma basis. UCB is listed on the Euronext Brussels Exchange and, through its affiliate, owns approximately 89 percent of the shares of SCHWARZ PHARMA AG. UCB's worldwide headquarters is located in Brussels, Belgium; the U.S. headquarters is located in Atlanta, Georgia. For more information about UCB, visit

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
2. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
3. SemBioSys updates Apo AI development program
4. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
5. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
6. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
7. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
8. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
9. Celebrity Designer Ty Pennington to Host ADHD Experts on Call Program
10. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
11. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
Post Your Comments:
(Date:11/24/2015)... Nev. , Nov. 24, 2015  PDL BioPharma, Inc. ... P. McLaughlin , the company,s president and chief executive officer, ... Healthcare Conference next week in New York City ... occur on Tuesday, December 1, 2015 at 9:30 a.m. EST. ... Please connect to the website at least 15 minutes prior ...
(Date:11/24/2015)... ... ... Laboratories is pleased to announce that it has completed construction on a new ... 61, USP 62 and USP 51 testing specific to raw materials and will enable ... by one supplier. Management has formally announced that the facility will be ...
(Date:11/23/2015)... CHICAGO , Nov. 24, 2015 Women with ... screening CT exams face a higher risk of lung cancer ... being presented next week at the annual meeting of the ... --> --> Lung ... are classified as solid or subsolid based on their appearance ...
(Date:11/23/2015)... KONG, Nov. 23, 2015 China Cord Blood ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its preliminary unaudited financial results for the ... ended September 30, 2015. --> ... , Revenues for the second quarter of fiscal ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):